Coherus BioSciences Management to Present at Three Investor Healthcare Conferences in September
September 01 2017 - 9:00AM
Coherus BioSciences, Inc. (Nasdaq:CHRS) today announced that senior
management will present at three upcoming investor healthcare
conferences.
- Management participation in a fireside chat is scheduled at the
Wells Fargo Healthcare Conference on Wednesday, September 6th at
8:30 a.m. ET taking place in Boston, MA.
- Management participation in a fireside chat is scheduled at the
Baird 2017 Global Healthcare Conference on Thursday, September 7th
at 9:05 a.m. ET taking place in New York, NY.
- A company presentation is scheduled at Cantor Fitzgerald’s 3rd
Annual Healthcare Conference on Tuesday, September 26th at 8:35
a.m. ET taking place in New York, NY.
The audio portion of the presentations will be available on the
investors page of the Coherus BioSciences website at
http://investors.coherus.com.
About Coherus BioSciences, Inc.Coherus is a
leading pure-play, global biosimilar company that develops and
commercializes high-quality therapeutics for major regulated
markets. Biosimilars are intended for use in place of existing,
branded biologics to treat a range of chronic and often
life-threatening diseases, with the potential to reduce costs and
expand patient access. Composed of a team of proven industry
veterans with world-class expertise in process science, analytical
characterization, protein production, sales & marketing and
clinical-regulatory development, Coherus is positioned as a leader
in the global biosimilar marketplace. Coherus is advancing three
late-stage clinical products towards commercialization, CHS-1701
(pegfilgrastim biosimilar), CHS-1420 (adalimumab biosimilar) and
CHS-0214 (etanercept biosimilar), as well as developing a robust
pipeline of future products in four therapeutic areas, oncology,
immunology (anti-TNF), ophthalmology and multiple sclerosis. For
additional information, please visit
www.coherus.com.
CONTACT:
Patrick O'Brien
Senior Vice President, Investor Relations
Coherus BioSciences, Inc.
pobrien@coherus.com
+1 (650) 649-3527
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Apr 2023 to Apr 2024